University Of Florida Enhanced Mammograms For Earlier Detection To Undergo Trial

August 17, 1998

GAINESVILLE, Fla.--A major University of Florida research effort to improve breast exam X-ray images using computers will undergo its first trial this fall, when radiologists determine whether the more detailed mammograms better show early signs of breast cancer.

The trial for the digitally enhanced mammograms comes shortly before new digital mammography systems reach the market. The machines are expected to gradually replace traditional X-ray methods.

"The advent of the digital machines is one more reason to process the images using computers, because when you have everything in digital form already it's not difficult to do some enhancing," said Iztok Koren, a postdoctoral associate in electrical and computer engineering and one of several engineers and medical professionals who have worked on the project.

Early detection is vital to successful treatment of breast cancer, the second major cause of cancer death in American women, according to the American Cancer Society (ACS). Some 178,700 cases have been diagnosed this year, with about 43,900 deaths.

Signs of breast cancer usually show up in a mammogram before women or health-care practitioners identify suspicious lumps by touch. But experts say as many as 30 percent of mammograms found negative for potentially cancerous lesions are actually positive.

The problem rests partly with human ability. X-ray images of breasts often appear cloudy and ill-defined, and radiologists have varying degrees of success identifying early tumors or potential tumors based on experience and skill. Also, the eye can distinguish between only 100 shades of gray, far less than the thousands recorded in X-ray detectors.

Medical professionals long have recognized enhancing mammographic images electronically could highlight suspicious abnormalities, but doing so has proved a challenge. Some past attempts, for example, resulted in the introduction of features not present in the original mammogram, leading radiologists to suspect cancer where none existed.

Launched five years ago with a $1.4 million grant from the U.S. Army Breast Cancer Research Program, the UF project uses mathematical tools to separate the mammogram image into distinct components, then puts them back together in a form that highlights irregular or suspicious features. The method achieves this goal through decomposing the image in different orientations and scales, modifying it to enhance lesions, masses, calcifications or other features that could prove cancerous, then reconstructing the image.

The images have shown considerable promise, said Andrew Laine, a former associate professor in the computer and information sciences department who spearheaded the UF group before joining Columbia University's department of biomedical engineering last year.

Laine, who continues to be involved with the project, said tests of the method on a simulated breast used to calibrate mammography machines found it successfully highlighted a mass that was not only invisible in the original mammogram but also was left undiscovered by other enhancement methods.

"Preliminary results are very strong," he said, adding radiologists who had perused the images informally gave them "rave" reviews.

In the trial this fall, researchers will enhance images from about 450 mammogram cases in a national database, then show them to about 10 general radiologists and six radiologists who specialize in diagnosing breast cancer at Shands hospital at UF, Laine said. The goal is to determine whether the enhancements will enable general radiologists to perform as well as specialized radiologists and whether they can improve specialized radiologists' performance, he said.

Others who have worked on the UF project include Fred Taylor, a UF professor of electrical and computer engineering; Janice Honeyman, an associate professor and director of informatics in Shands' radiology department; and Dr. Barbara Steinbach, former director of mammography at Shands and now medical director of the ETMC Breast Care Center in Tyler, Texas.

Color or black & white photo available with this story. For information, please call News & Public Affairs photography at (352) 392-9092.
-end-


University of Florida

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.